Seeking Alpha

Seeking Alpha Portfolio App for iPad

787 people get HOLX articles and Market Currents by email alert.

Get email alerts on HOLX »

HOLX

Hologic, Inc.

5/23/2013, 9:46 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Monday, May 6, 7:28 PM More on Hologic (HOLX): Company posts a mixed FQ2 report, beating on its EPS but missing on revenue. Net losses widened amid acquisition-related charges and other items which masked strong revenue growth. For the year, the company lowered its EPS estimate to between $1.54 to $1.56 on revenue of around $2.53B to $2.55B. For the current quarter, it now sees earnings of $0.36 to $0.37 on revenue of between $625M to $630M, below Street estimates for $0.41 on $655M, respectively. Shares -3% AH. Comment! [Healthcare, Earnings, On the Move]
Monday, May 6, 5:49 PM After-hours top gainers, as of 5:30 p.m.: SNTS +10%. MELI +9%. NLS +9%. ININ +6%. ROIC +6%.
After-hours top losers: RKUS -16%. NSPR -4%. AZPN -3%. HOLX -3%. AXL -3%. Comment! [On the Move]
Monday, May 6, 4:11 PM Hologic (HOLX): Q1 EPS of $0.35 beats by $0.01. Revenue of $619.1M misses by $20.43M. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Monday, May 6, 12:10 AM Notable earnings after Monday’s close: ALNY, AMTG, APC, ARRY, BSFT, CECO, CHUY, DPM, ENOC, EOG, FSLR, FST, FTR, GDP, GSM, GWAY, HIMX, HOLX, LGCY, MELI, MKTG, MMLP, MR, NOG, NRP, OTTR, PAA, PEGA, PNG, RKUS, SGY, SMG, SNTS, STAG, VNO, WMS Comment! [Earnings]
Sunday, May 5, 5:35 PM Notable earnings after Monday’s close: ALNY, AMTG, APC, ARRY, BSFT, CECO, CHUY, DPM, ENOC, EOG, FSLR, FST, FTR, GDP, GSM, GWAY, HIMX, HOLX, LGCY, MELI, MKTG, MMLP, MR, NOG, NRP, OTTR, PAA, PEGA, PNG, RKUS, SGY, SMG, SNTS, STAG, VNO, WMS Comment! [Earnings]
Friday, April 12, 5:53 PM After-hours top gainers, as of 5:15 p.m.: PLCM +4%. WLK +4%. IM +4%. ANV +4%. RES +4%.
After-hours top losers: USLV -4%. PTIE -3%. HOLX -3%. ARP -2%. RSH -2%. Comment! [On the Move]
Wednesday, February 6, 11:16 AM Hologic (HOLX -1.3%) slips after BAML cut the shares to Neutral on valuation earlier this morning. The bank says HOLX has ramped up 22% since early December and gotten far ahead of the 10% run-up the medical device group has seen over the same period. That coupled with a lack of catalysts in its FY13 guidance, give the stock limited upside from here. Read more on its earnings call guidance here: Earnings Call Transcript. Comment! [Healthcare, On the Move]
Tuesday, February 5, 11:03 AM Hologic (HOLX -1.5%) slips on a mixed FQ1 result late yesterday, beating on a per share basis but coming up just shy on the revenue side. Net profit plunged as the health- products company posted higher acquisition-related charges which masked strong revenue growth. Revenue from its breast-health segment grew by 2.5%, mostly on the growing installed base of the company's digital mammography systems, while its diagnostics revenue soared to $305.9M from $154.1M the year prior, getting a big boost from its Gen-Probe acquisition. Comment! [Healthcare, On the Move, Earnings]
Monday, February 4, 4:09 PM Hologic (HOLX): FQ1 EPS of $0.38 beats by $0.01. Revenue of $644.6M misses by $1.92M. Shares -1.2% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Monday, February 4, 12:10 AM Notable earnings after Monday’s close: ACLS, APC, APKT, ARRY, BIDU, EW, GGP, GILD, HI, HIG, HOLX, LEG, LIFE, MDU, MKL, SIMO, SWI, YUM Comment! [Earnings]
Sunday, February 3, 5:35 PM Notable earnings after Monday’s close: ACLS, APC, APKT, ARRY, BIDU, EW, GGP, GILD, HI, HIG, HOLX, LEG, LIFE, MDU, MKL, SIMO, SWI, YUM Comment! [Earnings]
Wednesday, January 9, 11:51 AM Hologic (HOLX +6%) gains after highlighting a new study published in the scientific journal Radiology, in which researchers using HOLX' 3D mammography technology in combination with a 2D mammogram found a significant increase in cancer detection rates, particularly for invasive cancers, and a simultaneous decrease in false-positive rates compared with 2D mammography alone. Comment! [Healthcare, On the Move]
Thursday, January 3, 5:18 PM After reviewing guidance for FY13 back in November, Hologic (HOLX) has decided to sell its Lifecodes business unit to Immucor (BLUD). Under the terms, HOLX will receive $85M in cash at closing and have the opportunity to earn a contingent payment of $10M based on achievement of certain financial targets throughout 2013. The transaction is expected to close during Q2. Comment! [Earnings, Healthcare]
Monday, November 12, 2012, 4:04 PM Hologic (HOLX): FQ4 EPS of $0.37 beats by $0.01. Revenue of $588M beats by $7M. Shares -1.4% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
Monday, November 12, 2012, 12:10 AM Notable earnings after Monday’s close: HOLX, JEC, NQ Comment! [Earnings]
Sunday, November 11, 2012, 5:35 PM Notable earnings after Monday’s close: HOLX, JEC, NQ Comment! [Earnings]